IO Biotech's first-in-class vaccine performs double duty, killing cancer cells and enhancing the tumor microenvironment. A ...

An executive order signed on Tuesday, May 15, necessitated a change in plans for this panel discussion from the 2025 ...

During National Asthma and Allergy Awareness Month, the high prevalence and costs of allergies and asthma in the US are ...

Duke Appiah, PhD, MPH, discusses maternal health disparities, emphasizing the impact of racial and ethnic factors on ...

Improving relationships between pharmaceutical makers, health systems, patients, and insurers can help to lower the price of ...

To better treat adolescent and young adult (AYA) patients with various subtypes of Hodgkin and non-Hodgkin lymphomas (NHL), ...

Higher health care needs, more financial barriers, and negative health care experiences defined the experiences of LGBTQ+ ...

New research suggests classical biomarkers cannot discriminate between refractory and non-refractory rheumatoid arthritis.

Participants in the CLL11 trial and a smaller group of patients followed after study completion showed improved overall ...

Approximately 1 million Aetna members will need new coverage with the announcement that CVS will be leaving the Affordable ...

The evolving role of artificial intelligence (AI) in cancer care was the topic of many conversations at the 2025 Community ...

Novo Nordisk's collaboration with telehealth providers offers semaglutide at $499/month, enhancing access for self-paying ...